later
Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing
peginterferon alfa-
2a/ribavirin treatment.Reddy KR, Shiffman ML, Morgan TR, Zeuzem S, Hadziyannis S, Hamzeh FM, Wright TL, Fried M.
University of Pennsylvania, Philadelphia, Pennsylvania, USA. rajender.